Send the following on WhatsApp
Continue to Chat食道癌療法新選擇!諾華(Novartis)公布三期結果可提升半年整體存活率 https://geneonline.news/novartis-tislelizumab-trial/?variant=zh-cn
食道癌療法新選擇!諾華(Novartis)公布三期結果可提升半年整體存活率 https://geneonline.news/novartis-tislelizumab-trial/?variant=zh-cn